Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 51 - 60 of 383

Selected Filters:
12 August 2024

PrEP Your Booty: The Launch of HPTN 106 “Rev Up”

Recording / Slides / Resources HPTN 106 (REV UP) is an innovative clinical trial from the HIV Prevention Trials Network that will investigate the safety and acceptability of a tenofovir-based rectal douche for HIV prevention among cisgender men and transgender women who have sex with men. Hear directly from researchers leading the study during this…

Research

Event
8 August 2024

Online pharmacy PrEP and PEP: Evidence, learnings, and recommendations from Kenya

Click here to access the recording. Private and community pharmacies, coupled with online pharmacy/telehealth platforms, hold promise as convenient pathways to enhance access and effective use of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). To generate evidence on the feasibility and effectiveness of an online pharmacy to support PrEP and PEP initiation, continuation, and PEP-to-PrEP…

Research, Service Delivery

Event
5 August 2024

PURPOSE 1 Summary

This factsheet provides a summary of the PURPOSE 1 phase III clinical trial of lenacapavir for PrEP and F/TAF for cisgender women taking place in South Africa and Uganda.

Research

Document
5 August 2024

Client Experiences with “Dynamic Choice Prevention,” a Model for Flexible Patient-centred HIV Prevention Delivery in Rural Eastern Africa

This article from Journal of the International AIDS Society discusses client experiences of a dynamic choice model for HIV prevention piloted in Kenya and Uganda under the SEARCH study, where clients were supported to select HIV prevention method, testing mode, and service delivery channel from a range of options.

Research, Service Delivery

External Link
30 July 2024

HIV Pre-Exposure Prophylaxis Policies Worldwide

An analysis presented at IAS2024, HIV Pre-Exposure Prophylaxis Policies Worldwide, by the Georgetown University Center for Global Health Policy & Politics, has found 69% of 194 countries reviewed have approved at least one PrEP product. But only 52% of the countries reviewed follow WHO guidance on PrEP eligibility with regulatory approvals and national policies that…

Normative Guidance/Policies, Research

Document
26 July 2024

Online Pharmacy PrEP and PEP: Technical considerations and learnings from Kenya

This document, developed by PATH, is intended as a how-to implementation guide for providing oral pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) via online pharmacy service delivery (ePrEP/ePEP) based on learnings and evidence from the ePrEP Kenya pilot study that ran from October 2022 through July 2024. The guide was developed to support ministries of…

Research, Service Delivery

Document
22 July 2024

Coordinating Implementation Science: PrEP and the Role of HIV Self-Testing

This document summarises key takeaways from a June 2024 BioPIC Think Tank to review and discuss opportunities and challenges in the scale-up of HIV self-testing for PrEP initiation and continuation.

Research, Service Delivery, Testing

Document
19 July 2024

Coordinating Implementation Science for CAB for PrEP: HIV Testing

This document summarises key takeaways from a June 2024 BioPIC Think Tank to review and discuss emerging issues around cabotegravir (CAB) for PrEP implementation and HIV testing algorithms.

Research, Service Delivery, Testing

Document
19 July 2024

Advocates’ Guide to Multipurpose Prevention Technologies (MPTs)

Multipurpose prevention technologies (MPTs) are products designed to simultaneously address more than one sexual and reproductive health concern. This advocates’ guide shows the pipeline of products in development, discusses why MPTs are needed, investment, and what advocates can do to push for MPT development and introduction.

Community/Advocacy, Research

Document
19 July 2024

Women’s Preferences for HIV Prevention Service Delivery in Pharmacies during Pregnancy in Western Kenya: A discrete choice experiment

This article from Journal of the International AIDS Society describes the results of a discrete choice experiment to evaluate where and how pregnant and lactating people in western Kenya preferred to access HIV prevention services, including PrEP.

Research, Service Delivery

External Link